글로벌 이소부티릴-CoA 탈수소효소 결핍증 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 이소부티릴-CoA 탈수소효소 결핍증 치료 시장

이소부티릴-코아 탈수소효소 결핍증 치료 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 5.30%의 CAGR로 성장할 것으로 분석합니다.

이소부티릴-코아 탈수소효소 결핍증(IBD 결핍증)은 발린 대사로 인해 발생하는 드문 선천적 오류입니다. ACAD8 유전자의 변화로 인해 발생합니다. 이 결핍증은 몇몇 단백질 의 분해를 방해합니다 . 일반적으로 단백질은 더 분해되어 성장과 발달에 에너지를 제공하는 아미노산을 형성합니다. 이 결핍증은 발린이라는 특정 아미노산을 분해하는 효소 수치가 부족합니다. 이 결핍증의 증상에는 심근병, 빈혈, 성장 부진, 발작 및 낮은 카르니틴 수치가 있습니다.

이소부티릴-CoA 탈수소효소 결핍증의 발생률 증가, 의료비 지출 증가, 첨단 치료에 대한 수요 증가, 정부의 높은 지원금, 유리한 보험금 지급 정책, 그리고 희귀 질병에 대한 인식을 확산하기 위한 정부와 민간 기관의 이니셔티브 증가는 이소부티릴-CoA 탈수소효소 결핍증 치료 시장을 확대할 요인입니다.

2021~2028년 예측 기간 동안 연구 개발 활동과 신흥 시장의 증가는 이소부티릴-CoA 탈수소효소 결핍증 치료 시장에 유익한 기회를 제공할 것입니다.

그러나 치료 비용이 높고 희귀 감염에 대한 인식이 부족한 것은 시장 성장을 방해하는 요소이며, 위에서 언급한 예측 기간 동안 이소부티릴-CoA 탈수소효소 결핍증 치료 시장에 더 큰 어려움을 초래할 것입니다.

This isobutyryl-coa dehydrogenase deficiency treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the isobutyryl-coa dehydrogenase deficiency treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Isobutyryl-Coa Dehydrogenase Deficiency Treatment Market Scope and Market Size

The isobutyryl-coa dehydrogenase deficiency treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the isobutyryl-coa dehydrogenase deficiency treatment market is segmented into L-carnitine, low-valine food diet and others.
• On the basis of diagnosis, the isobutyryl-coa dehydrogenase deficiency treatment market is segmented into new born screening, laboratory tests, physical examination and others.
• On the basis of dosage, the isobutyryl-coa dehydrogenase deficiency treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the isobutyryl-coa dehydrogenase deficiency treatment market is segmented into oral, intravenous and others.
• On the basis of end-users, the isobutyryl-coa dehydrogenase deficiency treatment market is segmented into clinic, hospital and others.

The isobutyryl-coa dehydrogenase deficiency treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Isobutyryl-Coa Dehydrogenase Deficiency Treatment Market Country Level Analysis

Isobutyryl-coa dehydrogenase deficiency treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the isobutyryl-coa dehydrogenase deficiency treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the isobutyryl-coa dehydrogenase deficiency treatment market due to the presence of major key players, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Isobutyryl-coa dehydrogenase deficiency treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Isobutyryl-Coa Dehydrogenase Deficiency Treatment Market Share Analysis

Isobutyryl-coa dehydrogenase deficiency treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to isobutyryl-coa dehydrogenase deficiency treatment market research.

이소부티릴-코아 탈수소효소 결핍증 치료 시장 보고서에 포함된 주요 기업으로는 Lonza, Merck Sharp & Dohme Corp., Northeast Pharmaceutical Group Co., Ltd., Cayman Chemical, Tokyo Chemical Industry Co. Ltd., Kaiyuan Hengtai Nutrition Co., Ltd., ChengDa PharmaCeuticals Co., Ltd., Avanscure Lifesciences Pvt. Ltd., Biosint SpA, Huanggang Huayang Pharmaceutical Co., Ltd., Merck KGaA, Viachem Limited, Spectrum Chemical Manufacturing Corp. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-66586